- Third-quarter 2014 operating earnings of 93 cents per share compared to guidance of 90 cents to $1.05 per share - Third-quarter 2014 GAAP earnings of 90 cents per share
- Year-to-date operating earnings per share up 15 cents, or 6 percent over 2013 - Company affirms 2014 operating earnings guidance of $3.35 to $3.65 per share RICHMOND, Va.
MSCI Inc. (NYSE:MSCI) announced today that it is proposing to issue $800
million aggregate amount of senior notes due 2024 in a private offering
that is exempt from the registration requirements of the Securities Act
of 1933, as amended (the “Securities Act”). The proposed offering is
subject to market and other conditions.
Monotype Imaging Holdings Inc. (Nasdaq: TYPE), a leading provider of
typefaces, technology and expertise for creative applications and
consumer devices, today announced financial results for the third
quarter ended Sept.
ITT Corporation (NYSE:ITT) today reported that third-quarter 2014 total
revenue grew by 4 percent to $657 million, reflecting growth in oil and
gas project pumps in North America, Latin America and the Middle East;
growth in the automotive brake pad aftermarket in Europe and market
share gains in China; and global growth in rail shock absorbers.
Oshkosh Corporation (NYSE: OSK) today reported fiscal 2014 fourth
quarter net income of $77.8 million, or $0.93 per diluted share,
compared to $35.7 million, or $0.40 per diluted share, in the fourth
quarter of fiscal 2013.
Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company
focused on delivering innovative therapies to patients with kidney
disease through the biology of hypoxia inducible factor (HIF), today
announced that John P.
Renewable Energy Group, Inc. (NASDAQ:REGI) is expanding its division
that sells heating oil and petroleum diesel along with biodiesel blends
by offering additional biofuel blends in New York, Minnesota and Iowa,
the company announced today.
NEW YORK, NY --
Sign-up for BioLineRx Reports Publication in Peer Review Journal of Results from Previous Phase 1/2 Trial for BCM (BL-1040), a Novel Medical Device for Prevention of Cardiac Remodeling Following Acute Myocardial Infarction investment picks
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.